Skip to main content
. 2024 Sep 25;38(3):1362–1373. doi: 10.1007/s10278-024-01267-8

Table 1.

Clinical characteristics of the patients in each cohort

Characteristics Total (n = 112) Training cohort (n = 68) Validation cohort (n = 22) P value* Test cohort (n = 22) P value**
Age, years, mean ± SD 51.4 ± 9.3 49.5 ± 9.5 52.0 ± 9.6 0.273 52.6 ± 8.6 0.174
Gender, n (%) 0.792 0.630
  Male 62 (55.4) 38 (55.9) 13 (59.1) 11 (50.0)
  Female 50 (44.6) 30 (44.1) 9 (40.9) 11 (50.0)
Height (cm) 167.6 ± 8.9 166.0 ± 8.7 167.1 ± 9.6 0.633 166.2 ± 9.0 0.949
Weight (kg) 68.2 ± 13.2 66.2 ± 12.5 65.4 ± 12.4 0.793 64.7 ± 11.7 0.613

Categorical data are shown as numbers (%), and continuous data are shown as means ± SDs

*The P value is the test result obtained with respect to the training cohort and the validation cohort

**The P value is the test result obtained with respect to the training cohort and the test cohort